Medicinska fakulteten, Lunds universitet

🚨 Job opening alert! 🚨 Application deadline December 11! We are now looking for a driven and methodologically skilled postdoctor in Environmental Epidemiology to join the ongoing project "Think before you ink – tattoos as a risk factor for immunologic disease" led by Christel Nielsen, Lunds universitet. 👉 More info about the position: https://lnkd.in/gjaJifeW 📖 Read about the tattoo project: https://lnkd.in/gzXiFYxF 🔎 Check out Christel Nielsen's profile in Lund University's research portal: https://lnkd.in/grDMg5ZE 👀 Watch the video about the research below or on YT: https://lnkd.in/ge6QnxjQ Welcome with your application! #research #epidemiology #tattoos #thinkbeforeyouink

🎉 Congratulations to Luís Oliveira, Lund Stem Cell Center and Filipe Pereira's research group, who just won the Researchers' Grand Prix 2024! 🎉 "Just like a hacker I use viruses, but on cells. I want to find the correct code to make the cancer cells their own worst enemies, so they start a war against themselves and we can find an effective therapy", says the winner. Researchers’ Grand Prix is a Swedish competition that has been running annually since 2012. Researchers are challenged to present their research in the most captivating, inspiring and educational way possible – in just four minutes! The audience and expert judges jointly decide on the winner. 📸 Bodil Malmström, Lund University Vetenskap & Allmänhet

🔦 In a study published in Advanced Science, researchers Fredrik Ek, Roger Olsson et al. describe how they can use light to create electrically conductive materials directly in the body, showing promising results in animal trials. "This has not been shown before for electrodes formed directly in tissues", says Fredrik Ek, researcher in chemical biology and drug development at Lunds universitet. Read full story here: https://lnkd.in/diJg8GdZ 📸 : Ingemar Hultquist #bioelectronics #bioelectronictreatment

🗓 Save-the-date! On January 7, registration opens for the 2nd Lund Spring Symposium: "Enabling Novel Therapeutic Principles", May 20-22, 2025

🎉 Today we celebrate the 10th anniversary of the National 7T MR facility in Lund and its recent upgrade! 🎉 🔹 Thanks to generous donations from Crafoordska stiftelsen and IngaBritt och Arne Lundbergs forskningsstiftelser and financial support from Region Skåne and Lund University the facility underwent a major state-of-the-art upgrade worth 21 MSEK in 2024. The upgrade will ensure that the facility remains at the forefront of ultra-high field MR research for at least another 10 years.   🔹The 7T magnetic resonance imaging system is owned by Lunds universitet through LBIC Lund University Bioimaging Centre and operates within the Centre for Imaging and Function at Skånes universitetssjukhus (Skåne University Hospital) in Lund making it an ideal hub for translational research! The facility is open to researchers from all Swedish universities.    🔹Under the supervision of Gunilla Westergren-Thorsson, director LBIC, Viktor Öwall, pro vice chancellor Lund University, Ebba Fischer, chair Crafoordska stiftelsen, Anna Mannfalk, chair Hälso- och sjukvårdsnämnden Region Skåne, and Christina Backman, chair IngaBritt och Arne Lundbergs Forskningsstiftelse, cut the ribbon to mark the inauguration of the new upgrade! ➡ Explore research possibilities at the 7 Tesla facility: https://lnkd.in/d_Bbzv8Z

Den 15 november uppmärksammar vi Filantropins dag, en dag då filantropins betydelse för vårt samhälle lyfts över hela världen! 💛🌍 Medicinska fakulteten vill rikta ett hjärtligt tack till alla donatorer som bidrar till fakultetens forskning och utbildning. Ert stöd och engagemang är ovärderligt och tillsammans bidrar vi till att hitta nya lösningar på de globala hälsoutmaningarna. Tack! 🌹

🐻 World Diabetes Day 2024 - The TEDDY study will soon be completed 🐻 🔷 The Environmental Determinants of Diabetes in the Young (TEDDY study) began in 2004 and includes almost 8,700 children from Sweden, Finland, Germany and the United States. The research project is funded by The National Institutes of Health and aims to ascertain what causes the development of type 1 diabetes in children. 🔷 In 2025, children within the TEDDY study will submit their final samples. Globally, 8667 children have participated in the TEDDY study. 💙We extend our heartfelt thanks to all the children and families who have generously contributed to our understanding of type 1 diabetes! 💙 🔷The most important lessons from the study are presented in Nature Reviews Endocrinology: - a connection between enterovirus infection, the development of diabetes-related autoantibodies and type 1 diabetes. - administering probiotics to infants at increased risk of developing the disease can reduce the risk of them developing diabetes-related autoantibodies. 🔷 Åke Lernmark, principal investigator of the TEDDY study in Sweden and professor Lunds universitet has led work on the article. Jeffrey Krischer, director of the TEDDY Data Coordinating Center and co-chair of the international TEDDY study and professor and director of the Health Informatics Institute at the University of South Florida is one of the leading co-authors.

Lunds universitet och Region Skåne inrättar gemensamt precisionsmedicinskt centrum som ska ge rätt diagnos och behandling till rätt patient. – Precisionsmedicin handlar om att förbättra behandlingar inom hälso- och sjukvården genom att hitta vilka individer som svarar bäst på behandlingen. Men också hitta de som inte har någon nytta av en viss given behandling. Vi vill maximera den medicinska nyttan av en behandling genom att ge den till dem som behöver den bäst, förklarar Olle Melander. Tillsammans med Sophia Zackrisson kommer Olle Melander leda det nya centrumet. Läs hela nyheten: https://lnkd.in/dDZ4VnQQ Region Skåne Lunds universitet #precisionsmedicin

Foam cells in brain tumours A research team Lunds universitet in Sweden has discovered a certain type of cells – foam cells – in patients with the aggressive brain tumour glioblastoma. It has been shown how these cells accelerate the cancer’s growth and that this can be successfully inhibited using a drug developed for arteriosclerosis. – We are the first ones who can show in tissue from patients how these foam cells act inside the tumour. The discovery of foam cells in glioblastoma is crucial in understanding the tumour biology behind the cancer and how a diseased environment interacts with the immune system’s cells and makes them a part of the problem,” says Mattias Belting who led the study together with postdoc Valeria Governa. Read about the study: https://lnkd.in/dfbG2Nmg #research #cancer #glioblastoma

🎉 Congratulations to Malin Parmar and her colleagues in Denmark and Italy - Jenny Emneus, Elena Cattaneo and Annalisa Buffo - to the ERC Synergy Grant!